Gene Therapy Advances: What Health Execs Should Know – ModernMedicine
|
Gene Therapy Advances: What Health Execs Should Know
ModernMedicine Although only three gene therapies have been approved in the United States—all in 2017—these innovative treatments are leaving their imprint on the healthcare system. Novartis' Kymriah (tisagenlecleucel), a chimeric antigen receptor (CAR)T-cell … |
